Cited by — Long-Term Safety and Efficacy of Dazukibart in Dermatomyositis: Combined Phase II Results From Double-Blind and Open-Label Extension Studies | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Long-Term Safety and Efficacy of Dazukibart in Dermatomyositis: Combined Phase II Results From Double-Blind and Open-Label Extension Studies.
No admitted local citation edges point to this work yet.
